Flagship Biosciences Company
Flagship Biosciences delivers comprehensive tissue profiling using our Artificial Intelligence (AI) enabled cTA® pathology platform.
Founded Date:
2009-01-01
Technology:
Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics
Investor Type:
For Profit
Funding Status:
Early Stage Venture
Total Funding:
15285339.0
Employee Number:
51-100
Headquarters:
Westminster, Colorado, United States
Last Funding Date:
2022-09-09
Last Funding Type:
Venture - Series Unknown
Estimated Revenue:
$10M to $50M
Industry:
End-to-End Drug Development